Return to Play After Non-Operative Management of Primary Anterior Shoulder Instability A Systematic Review.


Journal

Bulletin of the Hospital for Joint Disease (2013)
ISSN: 2328-5273
Titre abrégé: Bull Hosp Jt Dis (2013)
Pays: United States
ID NLM: 101614130

Informations de publication

Date de publication:
Jun 2023
Historique:
medline: 22 5 2023
pubmed: 18 5 2023
entrez: 18 5 2023
Statut: ppublish

Résumé

The purpose of the current study was to system-atically review the evidence in the literature to ascertain the rate of return to play and subsequent recurrence rates after first-time anterior shoulder instability in athletes. A literature search of MEDLINE, EMBASE, and The Cochrane Library was performed based on the PRISMA guidelines. Studies evaluating the outcomes of athletes with primary anterior shoulder dislocation were included. Return to play and subsequent recurrent instability were evaluated. Twenty-two studies with 1,310 patients were included. The mean age of included patients was 30.1 years, 83.1% were male, and the mean follow-up was 68.9 months. Overall, 76.5% were able to return to play, with 51.5% able to return to play at their pre-injury level. The pooled recurrence rate was 54.7%, with best-case and worst-case analysis revealing the recurrence rate to be between 50.7% to 67.7% in those able to return to play. Among collision athletes, 88.1% were able to return to play, with 78.7% experiencing a recurrent instability event. The current study demonstrates that non-operative management of athletes with primary anterior shoulder dislocation results in a low rate of success. While the majority of athletes are able to return to play, there is a low rate of return to their pre-injury level of play, and there is a high rate of recurrent instability.

Identifiants

pubmed: 37200329

Types de publication

Systematic Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

118-124

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH